Apimeds Pharmaceuticals US, Inc.

APUS

Apimeds Pharmaceuticals US, Inc. (APUS) is a pharmaceutical company focused on the development, manufacturing, and distribution of medical and health-related products. The company aims to provide innovative solutions in healthcare through its portfolio of specialized medicines and treatments.

$2.31 +0.03 (1.32%)
🚫 Apimeds Pharmaceuticals US, Inc. does not pay dividends

Related Companies

Aptiv PLC
Aptiv PLC
APTV
ActivePassive U.S. Equity ETF
ActivePassive U.S. Equity ETF
APUE
Asia Pacific Wire & Cable Corp
Asia Pacific Wire & Cable Corp
APWC
Aptevo Therapeutics Inc
Aptevo Therapeutics Inc
APVO